Debt-to-equity of Beam Therapeutics Inc. from 30 Sep 2020 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Beam Therapeutics Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2020 to 31 Dec 2025.
  • Beam Therapeutics Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 29%, a 40% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Beam Therapeutics Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 29% -20% -40% 31 Dec 2025
Q3 2025 36% -12% -25% 30 Sep 2025
Q2 2025 39% -13% -25% 30 Jun 2025
Q1 2025 43% -14% -24% 31 Mar 2025
Q4 2024 49% -14% -23% 31 Dec 2024
Q3 2024 48% -24% -33% 30 Sep 2024
Q2 2024 52% -26% -33% 30 Jun 2024
Q1 2024 57% -24% -30% 31 Mar 2024
Q4 2023 63% -18% -22% 31 Dec 2023
Q3 2023 72% -7.3% -9.2% 30 Sep 2023
Q2 2023 78% +12% +18% 30 Jun 2023
Q1 2023 81% +18% +29% 31 Mar 2023
Q4 2022 81% +22% +37% 31 Dec 2022
Q3 2022 80% +25% +47% 30 Sep 2022
Q2 2022 66% +2.8% +4.3% 30 Jun 2022
Q1 2022 63% +6% +10% 31 Mar 2022
Q4 2021 59% +15% +34% 31 Dec 2021
Q3 2021 54% +0.6% +1.1% 30 Sep 2021
Q2 2021 64% 30 Jun 2021
Q1 2021 57% 31 Mar 2021
Q4 2020 44% 31 Dec 2020
Q3 2020 54% 30 Sep 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.